Only three dividend kings passed this brutal screen. They could pay you well for years to come.

Only three dividend kings passed this brutal screen. They could pay you well for years to come.
Only three dividend kings passed this brutal screen. They could pay you well for years to come.

The longer the market remains noisy, the more attractive companies appear.

This is especially true when those companies have increased their dividends for more than 50 consecutive years, a consistency rare in any market. Rarer still are those that also generate strong payouts, healthy revenue growth, and outstanding long-term profits. Those are the names I wanted to focus on here today: three notable dividend kings.

Using Barchart’s Stock Screener, I selected the following filters to get my list:

  • % Annual Dividend Yield (FWD): It was left blank so it could be sorted later from largest to smallest.

  • 5-year percentage change: Greater than 50%. I look for stocks with more than 50% increase in the last 5 years.

  • 5-year dividend growth (%): Above 20%. Companies with dividend increases from “High” to “Very High”.

  • 5-year revenue growth (%): Above 30%. I am looking for companies with “Very High” income in the last 5 years.

  • Current Analyst Rating: “Moderate” to “strong” buy.

  • Number of analysts: 12 or higher. The more the better.

  • Dividend investing ideas: Dividend kings.

I ran the screen and got exactly three results, and I’ll cover each one, starting with AbbVie, which has the highest annual forward dividend yield.

AbbVie Inc. is a biopharmaceutical company that develops medicines for complex and long-term health conditions in immunology, oncology, neuroscience and aesthetics. It is also advancing in oncology: recent phase 2 data from ELAHERE show encouraging results in platinum-sensitive ovarian cancer.

In its most recent quarterly financial statements, the company reported that sales increased 10% year over year to $16.6 billion. Net income also rose more than 8.3% to $1.8 billion, after recovering from a net loss last year. Revenue also increased by 33.53% in the last 5 years.

Additionally, AbbVie pays a dividend of $6.92 per year per share, which translates to a yield of around 3.3%, the highest on this list. It also has five-year dividend growth of 40%, while the stock gained 87% over the same period.

With that, a consensus among 31 analysts rates the stock as a “Moderate Buy.” Finally, a high price target suggests there is upside potential of up to 43% over the next year.

The next dividend king on my list is Nucor Corp, one of North America’s largest steel producers, supplying steel and steel products used in construction, infrastructure, manufacturing and energy. That reach remains important as energy security attracts more attention, with Nucor providing steel for projects such as oil pipelines and other energy-related construction.

Source link